Cargando…
Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
A resurgence of interest and investment in the field of gene therapy, driven in large part by advances in viral vector technology, has recently culminated in United States Food and Drug Administration approval of the first gene therapy product targeting a disease caused by mutations in a single gene...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308217/ https://www.ncbi.nlm.nih.gov/pubmed/30591984 http://dx.doi.org/10.1007/s11095-018-2554-7 |